These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10979925)

  • 1. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
    Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
    J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
    J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.
    Marais DJ; Carrara H; Ramjee G; Kay P; Williamson AL
    J Med Virol; 2009 Feb; 81(2):203-10. PubMed ID: 19107974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.
    Marais DJ; Best JM; Rose RC; Keating P; Soeters R; Denny L; Dehaeck CM; Nevin J; Kay P; Passmore JA; Williamson AL
    J Med Virol; 2001 Sep; 65(1):149-54. PubMed ID: 11505457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
    Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G
    Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
    Viscidi RP; Snyder B; Cu-Uvin S; Hogan JW; Clayman B; Klein RS; Sobel J; Shah KV
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):283-8. PubMed ID: 15668510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus.
    Serwadda D; Wawer MJ; Shah KV; Sewankambo NK; Daniel R; Li C; Lorincz A; Meehan MP; Wabwire-Mangen F; Gray RH
    J Infect Dis; 1999 Oct; 180(4):1316-9. PubMed ID: 10479163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
    Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
    J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.
    Marais DJ; Constant D; Allan B; Carrara H; Hoffman M; Shapiro S; Morroni C; Williamson AL
    J Clin Microbiol; 2008 Feb; 46(2):732-9. PubMed ID: 18077644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of immunoglobulin IgA and IgG against human papilloma virus.
    Gonçalves AK; Machado PR; de Souza LC; Costa AP; Gimenes F; Consolaro ML; Crispim JO; Eleutério J; Giraldo PC
    Viral Immunol; 2014 Nov; 27(9):471-7. PubMed ID: 25191973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.
    Höpfl R; Petter A; Thaler P; Sarcletti M; Widschwendter A; Zangerle R
    BMC Infect Dis; 2003 Apr; 3():6. PubMed ID: 12723991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of IgA response among women with incident HPV 16 infection.
    Onda T; Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
    Virology; 2003 Jul; 312(1):213-21. PubMed ID: 12890634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.
    Fakhry C; D'souza G; Sugar E; Weber K; Goshu E; Minkoff H; Wright R; Seaberg E; Gillison M
    J Clin Microbiol; 2006 Dec; 44(12):4479-85. PubMed ID: 17021055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.